Search Within

Michael David Offin

  1. "2024"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (10)
  3. Review (2)
  4. Correspondence (1)
Groups
  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. Thoracic Oncology (23)
  4. Weinberg Fellows (23)
  5. Department of Pathology and Laboratory Medicine (15)
  6. GSK Faculty (13)

More Groups

People
  1. Marjorie Zauderer (11)
  2. Jennifer Sauter (10)
  3. Andreas Rimner (7)
  4. Michelle Ginsberg (7)
  5. Prasad Adusumilli (7)
  6. Charles Rudin (6)

More People

Years
  1. 2024 (23)
Publications
  1. Clinical Cancer Research (3)
  2. Journal of Clinical Oncology (3)
  3. Radiotherapy and Oncology (3)
  4. Annals of Oncology (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. American Society of Clinical Oncology (5)
  3. American Association for Cancer Research (3)
  4. Oxford University Press (2)
  5. Annual Reviews (1)
  6. Elsevier B.V (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Updated efficacy and safety from the phase II PHAROS study of encorafenib plus binimetinib in patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC)
    Meeting Abstract

    Riely, G. J.; Ahn, M. J.; Clarke, J.; Dagogo-Jack, I.; Felip, E.; Gelsomino, F.; Goldman, J. W.; Hussein, M.; Johnson, M. L.; Morgensztern, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Updated safety analysis of encorafenib plus binimetinib in patients with BRAF V600e-mutant metastatic NSCLC from PHAROS study
    Meeting Abstract

    Smit, E.; Ahn, M. J.; Dagogo-Jack, I.; Felip, E.; Gelsomino, F.; Johnson, B.; Johnson, M.; Negrao, M. V.; Offin, M.; Ramalingam, S.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Targeting TROP-2 in diffuse pleural mesothelioma
    Meeting Abstract

    Offin, M. D.; Tischfield, S.; Manoj, P.; Agrawal, P.; Tendler, S.; Pratt, E. C.; Travis, W.; Rimner, A.; Simone, C. B.; de Stanchina, E.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Multi-center phase I study of concurrent paxalisib and radiation therapy in patients with solid tumor brain metastases (BM) or leptomeningeal metastases (LM) harboring PI3K pathway mutations
    Meeting Abstract

    Imber, B. S.; Kotecha, R.; Blau, M. H.; Friend, J.; Young, R. J.; Offin, M.; Michelle, R.; Diamond, E.; Yang, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC
    Meeting Abstract

    Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • A model for approaching pathologic assessment of treatment response to neoadjuvant chemotherapy in resected pleural mesothelioma
    Meeting Abstract

    Aly, R. G.; Offin, M.; Tan, K. S.; Bodd, F.; Adusumilli, P.; Travis, W.; Zauderer, M.; Sauter, J.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with well-differentiated papillary peritoneal mesothelial tumors
    Journal Article

    Offin, M.; Aguirre, N.; Yang, S. R.; Sauter, J. L.; Karagkounis, G.; Mohamed, M.; Cercek, A.; Kundra, R.; Zhang, Y.; Wang, H. M.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer
    Journal Article

    Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save